Xue-Jun Wang Selected Research

Xue-Jun Wang Research Topics

Disease

8	Neoplasms (Cancer) 12/2022 - 03/2008
4	Neoplasm Metastasis (Metastasis) 08/2022 - 03/2008
3	Infections 01/2022 - 06/2004
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2008
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Crohn Disease (Crohn's Disease) 01/2022 - 01/2021
2	Altitude Sickness (Mountain Sickness) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2019 - 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Pain (Aches) 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	COVID-19 01/2020
1	Asymptomatic Infections 01/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Nevus (Nevi) 12/2018
1	Diabetes Mellitus 01/2018
1	Dyspepsia (Indigestion) 02/2017
1	Respiratory Paralysis 12/2016
1	Guillain-Barre Syndrome 12/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2020
2	Biological ProductsIBA 12/2022 - 05/2015
2	Long Noncoding RNAIBA 01/2022 - 12/2014
2	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2014
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
2	GlucocorticoidsIBA 01/2020 - 12/2016
1	Peptides (Polypeptides)IBA 12/2022
1	Sincalide FDA Link 08/2022
1	AdipokinesIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	AntibodiesIBA 01/2022
1	phosphatidylinositol 3-phosphateIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	notoginsenoside R1IBA 01/2021
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2021
1	AntipyreticsIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2021
1	remdesivirIBA 01/2020
1	qingfei paidu decoctionIBA 01/2020
1	umifenovirIBA 01/2020
1	UGT1A1 enzymeIBA 01/2020
1	favipiravirIBA 01/2020
1	Pregnane X ReceptorIBA 01/2020
1	Constitutive Androstane ReceptorIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Chloroquine (Aralen)FDA LinkGeneric 01/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2020
1	EnzymesIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	InterferonsIBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2020
1	LuciferasesIBA 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2020
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2020
1	Ritonavir (Norvir)FDA Link 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Cytochrome P-450 CYP3AIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Lopinavir FDA Link 01/2020
1	Cytochrome P-450 CYP2C9IBA 01/2020
1	talimogene laherparepvecIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	beta-tricalcium phosphateIBA 12/2018
1	qiliqiangxinIBA 01/2018
1	xiaoyaosanIBA 02/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2017
1	gamma-Globulins (gamma-Globulin)IBA 12/2016

Therapy/Procedure

5	Therapeutics 12/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 12/2022 - 01/2022
2	Moxibustion 01/2022 - 01/2021
2	Gastrectomy 03/2011 - 03/2008
1	Immunotherapy 12/2022
1	Oncolytic Virotherapy 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020
1	Extracorporeal Membrane Oxygenation 01/2020
1	Lung Transplantation 01/2020
1	Chemoprevention 01/2020
1	Noninvasive Ventilation 01/2020
1	Length of Stay 12/2016
1	Intravenous Injections 12/2016